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Abstract 
Background: Isothermal amplification techniques are emerging as a promising method for malaria diagnosis since 
they are capable of detecting extremely low concentrations of parasite target while mitigating the need for infrastruc‑
ture and training required by other nucleic acid based tests. Recombinase polymerase amplification (RPA) is promising 
for further development since it operates in a short time frame (<30 min) and produces a product that can be visually 
detected on a lateral flow dipstick. A self‑sealing paper and plastic system that performs both the amplification and 
detection of a malaria DNA sequence is presented.
Methods: Primers were designed using the NCBI nBLAST tools and screened using gel electrophoresis. Paper and 
plastic devices were prototyped using commercial design software and parts were cut using a laser cutter and assem‑
bled by hand. Synthetic copies of the Plasmodium 18S gene were spiked into solution and used as targets for the RPA 
reaction. To test the performance of the device the same samples spiked with synthetic target were run in parallel 
both in the paper and plastic devices and using conventional bench top methods.
Results: Novel RPA primers were developed that bind to sequences present in the four species of Plasmodium which 
infect humans. The paper and plastic devices were found to be capable of detecting as few as 5 copies/µL of synthetic 
Plasmodium DNA (50 copies total), comparable to the same reaction run on the bench top. The devices produce 
visual results in an hour, cost approximately $1, and are self‑contained once the device is sealed.
Conclusions: The device was capable of carrying out the RPA reaction and detecting meaningful amounts of syn‑
thetic Plasmodium DNA in a self‑sealing and self‑contained device. This device may be a step towards making nucleic 
acid tests more accessible for malaria detection.
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Background
There is growing interest in developing nucleic acid 
tests (NATs) that can be used to diagnose and monitor 
infectious diseases in low-resource areas [1, 2]. NATs 
are extremely sensitive and highly specific, but their 
widespread use at the point-of-care is hindered by high 
per-test cost, technical complexity and infrastructure 
requirements [3–5]. Isothermal amplification meth-
ods offer a promising avenue to reduce the cost and 
complexity of NATs, since they do not require a thermo-
cycler, thereby increasing global access to high quality 
diagnostics [6–9].
Recombinase polymerase amplification (RPA) is a 
recently developed isothermal amplification method that 
can produce detectable results in less time and at lower 
temperatures than other isothermal amplification tech-
niques; these advantages make it particularly suitable for 
use at the point-of-care. The RPA reactions operates in a 
manner similar to conventional PCR, using a forward and 
reverse primer to amplify a sequence of DNA. However 
instead of using heat to denature the target strand, the 
RPA reaction operates isothermally by using enzymes. 
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Recombinase is added to the master mix, which forms 
complexes with the primer strands. These recombinase-
primer complexes then displace the anti-sense strand of 
the target, binding the primers to the target strands and 
creating binding sites for polymerase to bind [10]. The 
RPA reaction can be modified (RPA nfo) with an internal 
probe sequence and a labelled primer to generate a prod-
uct which can be detected by a commercial lateral flow 
dipstick assay, allowing for visual readout of the result 
[11, 12].
Paper microfluidic devices offer a promising platform 
to translate isothermal amplification tests to the point-
of-care, since they are made of inexpensive materials, 
do not require pumps or other external apparatus and 
can replicate many of the functions of more traditional 
microfluidic devices [13, 14]. Recently, Rohrman et  al. 
presented a foldable paper and plastic microfluidic device 
to carry out the RPA reaction [15]. This system was used 
to amplify a target sequence in the HIV gag gene, and 
achieved detectable amplification of as few as 10 copies 
of HIV DNA in as few as 15  min. However a key limi-
tation of this system was that it required the user to cut 
the device open to extract and dilute the amplified prod-
uct for detection on lateral flow strips. Without dilution, 
the crowding reagent used in the RPA nfo buffer leads to 
false positive results on the lateral flow detection strips. 
The need to cut open the device and dilute the reaction 
products adds additional user steps and greatly increases 
the likelihood of contamination of the workspace with 
the amplified target, which in turn can lead to false posi-
tive results in future tests.
Here, an integrated device capable of carrying out 
isothermal amplification using the RPA reaction, post-
amplification dilution, and lateral flow detection of the 
resulting product is presented. This device is self-sealing 
and once loaded and sealed contains all reagents and 
mechanisms necessary to amplify, dilute and detect the 
product without the need to open the system.
As an example of a disease which would benefit from 
increased access to NAT-based diagnostics, this inte-
grated system was used to detect synthetic copies of a 
gene present in Plasmodium, the parasite which causes 
malaria [16]. There is a need for increased access to 
point-of-care malaria diagnostics which can detect the 
low-level infections which are often missed by thin and 
thick smear microscopy, the current gold standard [17–
19]. Several isothermal amplification techniques have 
been investigated as a method for diagnosing malaria, 
but RPA nfo offers advantages due to its short run time 
and easy visual detection scheme [20–27]. RPA nfo prim-
ers and a probe were developed which target a region 
common to all human infectious species of Plasmodium. 
The integrated paper and plastic system can be used to 
detect clinically relevant amounts of a synthetic copy of 
the Plasmodium 18S gene.
Methods
Materials
RPA nfo amplification kits and lateral flow detec-
tion strips (Milenia Hybridtech 1) were obtained from 
TwistDx Limited (Cambridge, UK). DNA primer, probe 
and target plasmid sequences were obtained from Inte-
grated DNA Technologies (Coralville, IA, USA) and 
all except the plasmid prepared by suspending them in 
water to a concentration of 10  µM. Materials for plas-
mid cloning and purification were ordered from Qia-
gen Inc. (Valencia, CA, USA). Sheets of 0.003″ acetate 
(KD3CL0811) and double-stick tape (KDT912-12) were 
obtained from Grafix (Maple Heights, OH, USA). Blot-
ter paper (CFSP223000) and glass fiber (GFCP203000) 
pads were obtained from Millipore Corp (Billerica, MA, 
USA). Whatman 1 Chromatography paper was obtained 
from Fisher Scientific Company LLC (Pittsburgh, PA, 
USA). Agarose, TAE, ethidium bromide, TBST and water 
were obtained from Sigma Aldrich (St. Louis, MO, USA). 
Screw top microcentrifuge tubes (used for all bench top 
reactions) were obtained from Genesee Scientific Corp 
(San Diego, CA, USA). 25 g metal weights were obtained 
from Amazon (Seattle, WA, USA).
Primer design and screen
Primers and a probe specific to the Plasmodium 18S gene 
were designed based on guidelines provided by TwistDx, 
the manufacturer of the RPA reaction, and were modi-
fied with end-tags and internal modifications to make 
them compatible with lateral flow detection. The target 
selected is the 18S gene because it is highly conserved, 
and contains regions shared amongst all species of Plas-
modium which commonly infect humans [28, 29]. For 
testing purposes, the target used was a synthetic plasmid 
containing a 2090 bp copy of the malaria 18S gene (total 
size of plasmid 5091 bp) (GenBank: MS19172). This plas-
mid was cloned into E. coli to increase copy number and 
purified using standard protocols [30]. Successful cloning 
and purification of the gene was confirmed by gel elec-
trophoresis on a 3 % agarose gel stained by ethidium bro-
mide. For all experiments, this purified target was then 
diluted in water to a concentration of 200, 50 and 5 cop-
ies/µL before being input to RPA nfo reactions along with 
an additional no target control of water.
The NCBI’s nucleotide BLAST tools were used to 
search for primers specific to Plasmodium without sig-
nificant overlap with other genomes. A variety of forward 
and reverse primer candidates were chosen and pairs 
were screened by observing their performance on a 3 % 
agarose gel stained with ethidium bromide and imaged 
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on a Bio-Rad Gel Doc XR+. Once the outer primer pairs 
were chosen, internal probes were screened through 
a similar process. The set of primers and probe with 
the brightest band on the gel were selected for further 
experimentation:
Forward primer: 5′-CACGAACTAAAAACGGCCATG 
CATCACCATCC-3′





The selected primers and probe target a sequence pre-
sent in the genome of all major species of Plasmodium, 
which infect humans, based on BLAST searches of the 
NCBI nucleotide database. This set of primers and probe 
produce a 218  bp primary product labelled only with 
biotin, as well as a 181  bp secondary product which is 
labelled for detection on the lateral flow strips.
To generate a product detectable on lateral flow strips, 
the 5′ end of the reverse primer is labelled with a biotin. 
A probe was designed that is labeled on its 5′ end with 
a FAM group, a C3 spacer (SpC3) on the 3′ end and a 
tetrahydrofuran residue (THF) which replaces an inter-
nal base. The RPA reaction produces a primary prod-
uct which is labelled with a biotin tag from the reverse 
primer. The probe binds internally to this primary prod-
uct, and once bound, the nfo enzyme in the reaction mix 
removes the THF and the bases 3′ to it, including the C3 
spacer. This allows the remaining bases of the probe to 
act as a new forward primer that produces a secondary 
product labelled with both biotin and FAM. This second-
ary product was detected using lateral flow strips func-
tionalized with streptavidin to capture the product at 
the test line and gold nanoparticles functionalized with 
anti-FAM to produce a color change at the test line in the 
presence of the labelled secondary product.
RPA reaction in solution
The RPA nfo reaction was carried out following the man-
ufacturer’s recommended protocols [10]. In brief, a mas-
ter mix was created containing 2.1 µL each of 10 µM of 
each primer, 0.6 µL of 10 µM of the probe, 3.2 µL of water 
and 29.5 µL of the reaction buffer included with the kit. 
In all experiments 37.5  µL of master mix was aliquoted 
into individual reaction tubes containing the freeze-
dried reaction pellet included with the kit. To each of 
these tubes 10  µL of target was added, and then 2.5  µL 
of 280 mM magnesium acetate (MgAc) was added to the 
cap of the reaction tube. Tubes were then briefly centri-
fuged and vortexed to mix MgAc with the other reagents. 
The reaction tubes were then incubated for 30 min in a 
heat block at 37 °C.
Lateral flow detection and imaging
Immediately after incubation, RPA reactions were 
removed from heat and 2  µL was removed and added 
to 98  µL of tris-buffered saline with 0.05  % tween-20 
(TBST), which was used as both sample diluent and 
lateral flow running buffer. This dilution step is neces-
sary because the dextran sulfate used as a crowding 
reagent in the RPA nfo buffer causes non-specific bind-
ing of the antibody labelled gold to the test line, generat-
ing a false positive. After dilution, 10 µL of the product 
was removed and spotted onto the end of a lateral flow 
strip. The strip was placed in a well containing 98 µL of 
TBST and allowed to run for 5 min. The strips were then 
scanned using a commercial document scanner (Epson 
Perfection V500 Photo) and images were recorded at 
1200 dpi using the ‘reflective document’ settings.
The signal-to-background ratio (SBR) of the lateral flow 
images were analysed using a custom MATLAB script. 
The user manually segments the test line and the sur-
rounding background region. The SBR is calculated by 
calculating the ratio of the average intensity of the signal 
and background regions [31].
RPA reaction in paper and plastic device
Device description
The paper and plastic device needs to carry out three 
main functions: (1) amplify the target using RPA; (2) 
dilute the resulting product; and (3) detect the prod-
uct using a lateral flow sandwich assay. In addition, the 
device must transfer the product between the ampli-
fication, dilution, and detection modules. A sequence 
of paper pads loaded with various reagents was used to 
carry out these functions. The amplification reaction is 
carried out on the RPA pad (Fig. 1A): a rectangular piece 
of Whatman number 1 paper which holds the RPA nfo 
reagents. The dilution function is carried out by four 
dilution pads (small squares of blotter paper), in two 
separate stages of dilution (Fig. 1B, C). Detection is car-
ried out using a commercial lateral flow strip (Fig.  1D) 
with running buffer delivered via a running buffer pad. 
To move amplified product from the amplification zone 
to each of the two dilution zones and then to the lateral 
flow strip, the sample pad (Fig. 1E), is physically moved 
across the other parts of the device. When the sample 
pad is placed in contact with another pad, passive diffu-
sion results in target transport to a subsequent zone of 
the device. To improve mixing during the amplification 
step, an extra pad of glass fiber is placed so that it will 
be in contact with the sample pad when the sample pad 
is in contact with the RPA pad. This mixing pad (Fig. 1F) 
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helps promote the diffusion of the RPA master mix onto 
the sample pad.
The case of the device is made of a symmetric L-shaped 
piece of acetate backed double-stick tape (Fig.  1G). 
The RPA pad, dilution pads and lateral flow strip are 
all attached to this base layer. The RPA pad is placed at 
the top of the L, followed by pairs of dilution pads along 
the vertical section of the L, and the lateral flow strip is 
placed along the base of the L. An acetate mask (Fig. 1H) 
is adhered to the remaining exposed adhesive of the base 
layer to prevent the device from adhering to itself when 
folded shut for use.
A slider is used to move the sample pad through the 
system. The slider holds the sample pad between two 
layers of acetate-backed tape with a hole cut through it 
to expose the surface of the sample pad. The slider has a 
long tail which sticks out through a slot in the base layer 
and is pulled to slide the sample pad between the dif-
ferent functional parts of the device (Fig.  1I). A second 
slider holds a running buffer pad (running buffer pad 
Fig.  1J, running buffer slider Fig.  1K), which is used to 
deliver running buffer to the lateral flow strip.
Device assembly
All device components were cut using a 60 W CO2 laser 
cutter (Universal Laser Systems, Scottsdale, AZ, USA). 
One side of a double stick tape sheet was exposed and 
adhered to acetate prior to cutting. Acetate backed pieces 
of tape were cut with contact paper side up. The fol-
lowing settings were used for each material: acetate 3 % 
power, 10 % speed; blotter paper 5 % power, 5 % speed; 
Whatman 1 paper 3 % power, 5 % speed; glass fiber 3 % 
power, 5  % speed; and cuts through the double-stick 
tape 7.5 % power, 10 % speed. After the acetate and tape 
base layer was cut, the outlines for each component were 
scored using a setting that cuts only through the contact 
paper (1.8 % power, 12 % speed).
To assemble the device, the contact paper was removed 
from the scored areas and the four dilution pads and the 
lateral flow strip were adhered to the base layer. The RPA 
nfo reaction pellet was placed on the exposed tape and 
the RPA pad pressed down on top to crush the pellet. The 
remaining paper (except for the separate border piece) 
was removed and the acetate mask was adhered to the 
base. The sample and running buffer sliders were assem-
bled. The tails of the finished sliders were threaded into 
the slots cut in the base layer.
Operation of device
To operate the device, the remaining border of contact 
paper is removed to expose the sticky edge that will be 
used to seal the device closed. The device is then loaded 
with wet reagents necessary for amplification, dilution 
and detection. 100 µL of TBST is added to the running 
buffer pad. An additional 40 µL of TBST is added to the 
two wet dilution pads. 37.5 µL of the RPA nfo master mix 
is added to the pad covering the RPA nfo pellet. Finally 
10 µL of the sample is added to the sample slider, along 
with 2.5 µL of MgAc. The device is then folded in half and 
sealed shut.
The sample slider begins centered over the RPA pad, 
position 1, so that when the device is sealed shut, the 
sample and RPA reagents mix together. To begin ampli-
fication, the entire device is placed on a hot plate set to 
37 °C and a 25 g metal weight is placed over the sample 
slider to ensure even heating and consistent mixing of 
reagents (Fig.  2a). After 30  min, the device is removed 
from the hot plate and the sample slider is pulled down to 
position 2, placing it in contact with the dry dilution pads 
and the weight is placed over top of it (Fig.  2b). After 
10 min, the slider and weight are moved to position 3 in 
contact with the wet dilution pads for ten more minutes 
Fig. 1 Layout and components of the paper and plastic amplifica‑
tion and detection device. The device is shown in its configuration 
just before it would be loaded with wet reagents. The sample sliders 
are shown off to the side for clarity. The slots where they would be 
inserted, which are cut into the hinge where the device folds shut, 
are highlighted with an oval outline. The components of the device are 
A the RPA pad; B the dry dilution pads; C the wet dilution pads; D the 
lateral flow strip; E the sample pad; F the mixing pad; G the base layer; 
H the acetate mask; I the sample slider; J the running buffer pad; and 
K the running buffer slider
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(Fig. 2c). Finally, the sample pad is moved down to posi-
tion 4 over top of the lateral flow strip, the running buffer 
slider is also pulled down to the strip, and the weight is 
placed on top (Fig.  2d). The strip is allowed to run for 
5 min, and then the device is scanned.
To test and optimize the dilution zone, 0.25 % Ponceau 
S dye was used in place of sample to monitor the move-
ment of fluid through the system. All other components 
were loaded as if an amplification reaction was to be run. 
After amplification and dilution, rather than running the 
lateral flow strip, the device was cut open and the sample 
pad was removed and placed in 90 µL of TBST, vortexed, 
and the concentration of dye in solution was measured 
using a Cary 50 Spectrophotometer.
Results
The Plasmodium primers produced the expected primary 
and secondary amplicons based on agarose gel analysis of 
the products (Fig.  3a) and achieved a limit of detection 
(LOD) of 5  copies/µL (50 total copies) using visual 
inspection of the lateral flow strips (Fig.  3b). The visual 
result was confirmed by using SBR to objectively deter-
mine if a strip was positive or not. A strip was consid-
ered positive if it had a SBR that was greater than three 
standard deviations above the averaged SBR of negative 
control strips. Using this cutoff, the limit of detection of 
the assay, at which all samples were positive in every test, 
was also 5 copies/µL (50 total copies).
Using dye to track the flow of fluids, the slider sys-
tem was capable of reliably moving fluids through the 
system and transferring them to subsequent pads. The 
number of dilution pads, their size, the amount of buffer 
they were loaded with and the time spent on each pad 
were all varied as experimental conditions. After opti-
mization of the dilution system, two pairs of blotter 
paper pads were used, one wet and one dry, to achieve 
the necessary dilution. The dry dilution pads were used 
to remove some fluid on the sample pad so that it could 
Fig. 2 Device in operation. For clarity the weight which would rest over the location of the sample pad has been omitted and the edges of the 
sample and running buffer sliders have been outlined. a Sample slider at position 1, mixing RPA reagents and target and allowing amplification to 
occur (30 min). b After amplification, the sample slider pulled down to position 2, in contact with dry dilution pads to absorb RPA buffer (10 min). c 
The sample slider pulled down to position 3, in contact with wet dilution pads, for dilution with TBST (10 min). d Sample slider pulled down to posi‑
tion 4 into contact with lateral flow strip. The running buffer slider is pulled down to activate the strip (5 min)
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be replaced with TBST at the wet dilution pads. It was 
found that by letting the fluids exchange for 10  min on 
each set of pads under a 25 g weight, a final dilution of 
1:49 (2.04 % ± 0.26 % dilution, n = 5) could be achieved. 
No false positives due to lack of RPA buffer dilution were 
observed using this design.
The total run time for the device is 55  min (30  min 
incubation, 20  min dilution and 5  min lateral flow 
detection). Including the loading and operation of the 
device, the entire assay can be carried out in about an 
hour. To test the performance of the system, the same 
samples were simultaneously run side-by-side using 
both conventional bench top methods and the paper 
and plastic devices. Both methods were found to have a 
limit of detection of 5 copies/µL (50 total copies) using 
visual inspection and objective analysis by SBR (Fig. 4). 
Although the limit of detection was unaffected, the 
devices consistently had a lower SBR than the assay run 
on the bench top. At both 200 and 50  copies/µL there 
was approximately a 30 % reduction in the average SBR. 
There was less than a 5 % difference at both 5 copies/µL 
and in the no target controls. The reduced SBR at higher 
target concentrations may be due to two factors: running 
the assay in a paper matrix may reduce the mixing in the 
system compared to running it in a tube. Additionally, 
it was found that the plastic layered overtop of the lat-
eral flow strip increases the signal over both the test line 
and the background of the strip driving the SBR closer 
to unity.
Discussion
A novel set of primers have been developed which 
detects a sequence shared amongst the major human 
infectious species of Plasmodium and which can detect 
at least 5 copies/µL (50 total copies) of a plasmid contain-
ing a synthetic copy of a Plasmodium gene. This detect-
able concentration is comparable to other isothermal 
amplification methods for malaria and below the LOD 
of thin smear microscopy, the gold standard for malaria 
diagnosis [16, 32]. These primers are used with RPA nfo, 
an isothermal amplification method which can run at 
relatively low temperatures, which produces results in as 
few as 35  min when run on the bench top. A commer-
cially available assay for malaria which uses the LAMP 
isothermal amplification technique has been developed 
which is capable of detecting around 2 copies/µL (5 total 
copies) [26, 27]. Although the RPA nfo reaction detects 
fewer copies, the concentration at which it becomes posi-
tive is on the same order as LAMP and other isothermal 
techniques, and RPA nfo may offer advantages such as a 
shorter amplification run time and a readout on lateral 
flow strips [16].
A paper and plastic device was created which is capable 
of running the amplification reaction, diluting the ampli-
fied product by a repeatable amount and running the 
results on an included lateral flow dipstick. The device 
is made of simple components, can be assembled by the 
user and uses a novel slider method to transport reagents 



























Fig. 3 Performance of RPA nfo reaction and Plasmodium primers and probes in benchtop reactions. a An agarose gel stained with ethidium bro‑
mide showing the amplification of the primary (218 bp) and secondary (181 bp) products. b An example of the products run on lateral flow strips. 
Note that the positive result at 5 copies/µL of target is easier to determine on the strips than on the gel
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device itself and the sample to be tested are a hot plate 
capable of 37  °C, a reusable 25 g metal weight, the RPA 
master mix, the running/dilution buffer (TBST) and 
pipettes to load these reagents onto the device dilution, 
running buffer, RPA and sample pads. This device runs 
the entire assay, including detection, in around an hour 
and has a limit of detection equivalent to when the assay 
is run using conventional methods on the bench top. 
Excluding the cost of the lateral flow strip and the RPA 
nfo reaction pellet, the device costs around $1.05. The 
commercial lateral flow strips cost around $3.14 each, 
and the primers and RPA nfo reaction kits together cost 
approximately $4.09. This gives an approximate total 
reaction cost of $8.28 per test, most of which is due to 
the cost of the commercial components rather than the 
paper and plastic device.
A key limitation of the current work is that while a 
self-contained system for running the reaction was pre-
sented, it requires the user to add set amounts of fluid 
to various pads before sealing and operating the device. 
This means that the system requires roughly the same 
amount of manipulation as running the reaction on the 
bench top. Future work could reduce the external parts 
needed by integrating buffer and primer storage into the 
device, perhaps by drying them on the pads. In addition, 
the dilution system used increases the runtime of the 
assay by 20 min. Although much of this time is hands-off, 
future work should increase the run speed of the device 
by developing a more efficient method for diluting the 
sample. A study should be also be conducted to ensure 
that the seal of the device is adequate, and that aerosols 
cannot escape from the device in sufficient quantity to 
become a source of future contamination.
This study was aimed at developing a proof-of-con-
cept device and used synthetic targets. In order for the 
paper and plastic devices to be more useful in real world 
settings, the assay should be tested and optimized on 
infected and un-infected blood samples. Clinical samples 
will offer a number of additional challenges compared 
to the synthetic targets used in this study such as back-
ground human DNA and other blood components. Sam-
ple preparation techniques capable of lysing blood and 
extracting DNA in a manner compatible with the RPA 
nfo assay will need to be developed. Recently, there have 
been a variety of studies which have examined meth-
ods to run PCR and isothermal amplification on clinical 
malaria samples with minimal need for extra processing 
or equipment by using for example, a simple lysis tech-
nique such as detergents or heat, adapting the amplifica-
tion protocol to reduce the inhibitory effects of blood, 
and/or packaging the lysis and amplification together in 
a matrix such as a hydrogel [33–35]. Once a suitable sam-
ple preparation method has been determined, further 
work should be done to test the paper and plastic device 
on clinical samples, and, if possible, to continue to add 
more functions, such as the sample preparation directly 
to the device.
Conclusion
A novel set of primers was developed which amplify a 
sequence which is common to the human infectious spe-
cies of Plasmodium and operate an isothermal ampli-
fication reaction which is rapid and has an easy visual 
readout. A paper and plastic device was also developed 
which carries out the amplification of the samples, dilutes 
the product and runs the result on a lateral flow strip. 
When tested on synthetic targets, a limit of detection of 
5  copies/µL (50 total copies) was found, which matches 
the performance of the same assay run on the bench top. 
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Fig. 4 Demonstration of performance of paper and plastic device. a Representative images of the lateral flow strips run in the devices. b Compari‑
son of the averaged SBR of samples run in the device and in tubes (n = 3), the error bars represent ±1 standard deviation. Strips were positive by 
SBR if they were more than 3 standard deviations above the averaged no target control SBR, shown as a dotted line on the figure
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reagents are added and needs only a 37  °C heat source, 
reusable weight and timer. This device is a step towards 
a fully self-contained and easy to operate low-resource 
appropriate nucleic acid test for malaria diagnosis.
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